As validated in Kapan-Meier Plotter, overexpression of CENPF predicted worse OS (overall survival; HR = 1.54, log rank P = 0.013) and PFS (progression-free survival; HR = 1.77, log rank P = 0.00013) in HCC (Figures 5A-B). Here, CENPF is linked to hepatocellular carcinoma.